Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) revenue is $784.5M
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) revenue is $784.5M as of 2025-09-30. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.
Read the full AMRX research page for quote, filings, and the rest of the model. This satellite exists so “Amneal Pharmaceuticals, Inc. Class A Common Stock revenue” can rank with the actual number, then send you to /stock/amrx.